Redirected Strategy: Tal and TEC in the Myeloma Mix | Blood Cancers Today
Gurbakhash Kaur, MD joins the host of The HemOnc Pulse Live! for a comprehensive discussion about the RedirecT-1 trial.
Gurbakhash Kaur, MD joins the host of The HemOnc Pulse Live! for a comprehensive discussion about the RedirecT-1 trial.
The last 2 decades have seen a paradigm shift in the treatment landscape of metastatic gastric and gastroesophageal adenocarcinomas, with most of the progress occurring…
Unmet Palliative Care Needs in Patients With Multiple Myeloma
Armored CAR-T therapy effective for relapsed lymphoma, with 81% response rate. Read SOHO Insider’s insights.
Following former President Joseph R. Biden Jr.’s prostate cancer diagnosis, the Physicians Committee for Responsible Medicine, a nonprofit with 17,000 doctor members, is sharing resources…
If you’re trying to build muscle, getting enough protein is a must. But does it matter if that protein comes from meat or plants? A new…
Silke, Tom and Brian discuss what they are looking forward to at ASCO 2025
A recent review found loco-sedative anesthesia to be a promising technique for various urologic interventions, supporting procedures safely and effectively.
Philippe Armand, MD highlights the benefits of using checkpoint inhibitors earlier in salvage therapy for relapsed/refractory Hodgkin lymphoma, improving progression-free survival.
The agent targets abnormal gene expression in order to control the excessive cell proliferation that occurs in PV.
The developed scale strengthens the investigation of global irritable bowel disease epidemiology.